Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.
Clinical trial NCT00645502 · COMPLETED
Trial details
- NCT number
- NCT00645502
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.